EXOZ insider trading
NasdaqCM HealthcareEXOZYMES INC.: insider trade history from SEC Form 4 filings.
About EXOZYMES INC.
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Company website: www.exozymes.com
EXOZ insider activity at a glance
FilingIQ tracks 19 insider transactions for EXOZ in filings since Jun 17, 2025. The most recent transaction is dated Aug 26, 2026.
Across the full history, 6 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on EXOZ insider trades is 59.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest EXOZ Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for EXOZ?
- FilingIQ tracks 19 Form 4 insider transactions for EXOZ (EXOZYMES INC.), covering filings from Jun 17, 2025 onwards. 8 of those are dated within the last 90 days.
- Are EXOZ insiders net buyers or net sellers?
- Across the full Form 4 history for EXOZ, 6 transactions (32%) were open-market purchases and 2 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does EXOZ insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is EXOZ in?
- EXOZYMES INC. (EXOZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $84.87M.
Methodology & sources
Every EXOZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.